Kamal Malhotra is a Postdoctoral fellow in the laboratory of Dr. Darryl Davis at the University of Ottawa Heart Institute. She is working on project entitled ‘Controlled delivery of extracellular vesicle-based therapies for atrial fibrillation’. She obtained her PhD from Indian Institute of Technology Ropar and has been working on developing biomaterials for several biomedical applications. Previously, she worked at the Centre de Recherche de l'Hôpital Maisonneuve-Rosemont and University of Montreal as a Postdoctoral fellow under the supervision of Prof. May Griffith. At CRHMR, she was working on developing anti-infective peptides for corneal HSV-1 infection. Her research interest lies in self-assembled peptide gels, hydrogels, tissue engineering and targeted drug delivery.